We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Archer Daniels Midland
ADM
$40.1B
| $5.46M | 0.04% |
136,723
-8,750
| -6% | -$328K |
|
|
WMGI
302
DELISTED
Wright Medical Group Inc
WMGI
| $5.45M | 0.04% |
183,316
+55,453
| +43% | +$1.62M |
|
303
FIVE9
FIVN
$2.08B
| $5.43M | 0.04% |
49,083
-1,958
| -4% | -$191K |
|
304
Expedia Group
EXPE
$35.5B
| $5.42M | 0.04% |
65,911
-4,218
| -6% | -$307K |
|
305
Johnson Controls International
JCI
$85.6B
| $5.38M | 0.04% |
157,427
-10,075
| -6% | -$310K |
|
306
Dollar Tree
DLTR
$24.4B
| $5.37M | 0.04% |
57,972
-115
| -0.2% | -$9.59K |
|
307
GDS Holdings
GDS
$6.14B
| $5.34M | 0.04% |
66,984
+29,056
| +77% | +$1.8M |
|
308
AudioCodes
AUDC
$249M
| $5.33M | 0.04% |
167,663
+50,949
| +44% | +$1.57M |
|
309
VF Corp
VFC
$7.16B
| $5.31M | 0.04% |
87,116
-5,574
| -6% | -$325K |
|
310
LGI Homes
LGIH
$1.43B
| $5.29M | 0.04% |
60,134
+38,387
| +177% | +$2.69M |
|
311
Elevance Health
ELV
$83.7B
| $5.29M | 0.04% |
20,118
-415
| -2% | -$111K |
|
|
ETFC
312
DELISTED
E*Trade Financial Corporation
ETFC
| $5.25M | 0.04% |
105,462
| – | – |
|
313
Sportsman's Warehouse
SPWH
$45.7M
| $5.24M | 0.04% |
+367,776
| New | +$3.46M |
|
|
MGP
314
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $5.22M | 0.04% |
191,780
-143,000
| -43% | -$3.68M |
|
315
Schrodinger
SDGR
$1.14B
| $5.19M | 0.04% |
+56,676
| New | +$3.3M |
|
316
LPL Financial
LPLA
$27.4B
| $5.17M | 0.04% |
65,896
+12,975
| +25% | +$867K |
|
317
Zimmer Biomet
ZBH
$18.5B
| $5.12M | 0.04% |
44,200
-2,829
| -6% | -$326K |
|
318
Avery Dennison
AVY
$12.9B
| $5.01M | 0.04% |
43,958
-2,813
| -6% | -$309K |
|
319
MetLife
MET
$62.7B
| $4.94M | 0.03% |
135,376
-8,663
| -6% | -$302K |
|
320
UDR
UDR
$12.7B
| $4.93M | 0.03% |
132,029
-8,450
| -6% | -$315K |
|
321
Winnebago Industries
WGO
$908M
| $4.91M | 0.03% |
+73,671
| New | +$3.76M |
|
322
Xylem
XYL
$29.7B
| $4.88M | 0.03% |
75,094
-4,805
| -6% | -$317K |
|
323
Allegion
ALLE
$13.7B
| $4.85M | 0.03% |
47,419
-3,034
| -6% | -$299K |
|
324
FedEx
FDX
$74B
| $4.85M | 0.03% |
34,569
-2,212
| -6% | -$278K |
|
325
Gartner
IT
$10.4B
| $4.82M | 0.03% |
39,710
-2,541
| -6% | -$294K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.